The needs of the pharma industry are always evolving – and analytical techniques must advance to remain relevant or adapt to fulfill new demands. Here, I describe how mass data is marching from R&D into more routine use: the search for genotoxic impurities.
1
min read
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.